期刊文献+

C5b-9在坏死性肌病肌肉组织血管中的表达及意义 被引量:4

Role of C5b-9 expression in skeletal muscle blood vessels in necrotizing myopathy
下载PDF
导出
摘要 目的研究C5b-9在坏死性肌病肌肉小血管中的表达以探讨其发病机制。方法采用酶组织化学和免疫组织化学方法检测坏死性肌病患者肌肉组织肌纤维和血管的MHC-1和C5b-9表达。结果本组患者肌肉组织出现灶性或散在分布的肌纤维坏死,间有吞噬现象,肌内、外衣和血管周围未见炎性细胞浸润,局部小血管数量减少,个别小血管管壁增厚。MHC-I免疫组化染色显示坏死的肌纤维、肌纤维间隙及血管均呈阴性。C5b-9免疫组化染色显示肌肉组织的小动脉与小静脉的血管壁,内皮细胞及平滑肌均出现明显的强阳性表达,同时相关的坏变和萎缩肌纤维也出现明显的表达。结论 C5b-9可能参与血管启动的坏死性肌病的发病机制。 Objective To investigate the expression of C5b-9 in the skeletal muscle blood vessels in patients with necrotizing myopathy and explore its role in the pathogenesis of this disease.Methods The expression of C5b-9 and MHC-I in the skeletal muscular fibers and blood vessels in 4 patients with necrotizing myopathy was detected using enzymohistochemistry and immunohistochemistry.Results Focal or dispersive necrotic muscle fibers with obvious phagocytosis were observed in all the 4 patients.No inflammatory cell infiltration was found in the perimysium or perivascular regions.HE staining showed a decreased number of local small blood vessels,and the some small blood vessels showed thickened vascular walls.Immunohistochemistry detected prominent C5b-9 expression in the necrotic muscle fibers and the blood vessels,and diffuse strong C5b-9 expression was found in the vascular walls,vascular endothelial cells and the smooth muscle layer.No MHC-I deposition was detected in the muscular fibers and blood vessels.Conclusion C5b-9 contributes to the pathogenesis of necrotizing myopathy mediated by pathologies in the blood vessels.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第5期714-717,共4页 Journal of Southern Medical University
基金 首都临床特色应用研究(Z111107058811108)
关键词 坏死性肌病 C5B-9 肌纤维 内皮细胞 necrotizing myopathy C5b-9 muscle fibers endothelial cells
  • 相关文献

参考文献12

  • 1Grable-Esposito P,Katzberg HD,Greenberg SA,et al.Immune-mediated necrotizing myopathy associated with statins[J].MuscleNerve,2009,41:185-90.
  • 2Dalakas MC.Pathophysiology of inflammatory and autoimmunemyopathie[s J].La Presse Medicale,2011,40:e237-47.
  • 3Mammen AL.Autoimmune myopathies:autoantibodies,phenotypesand pathogenesi[s J].Nat Rev Neurol,2011,7:343-54.
  • 4Soane L,Rus H,Niculescu F,et al.Inhibition of oligodendrocyteapoptosis by sublytic C5b-9 is associated with enhanced synthesisof Bcl-2 and mediated by Inhibition of caspase-3 activation[J].JImmunol,1999,163:6132-38.
  • 5Soane L,Cho HJ,Niculescu F,et al.C5b-9 terminal complementcomplex protects oligodendrocytes from death by regulating Badthrough phosphatidylinositol 3-kinase/akt pathway[J].J Immunol,2001,167:2305-11.
  • 6佟建霞 ,王迎伟 .亚溶解型补体C5b-9复合物与细胞内信号转导通路[J].国外医学(免疫学分册),2005,28(6):376-380. 被引量:3
  • 7周镜然,白云,朱锡华.补体攻膜复合物细胞非致死性效应及其信号转导机制[J].免疫学杂志,2000,16(z1):1-4. 被引量:2
  • 8Cybulsky AV,Papillon J,McTavish AJ,et al.Complement-inducedphospholipase A2 activation in experimental membranousnephropathy[J].Kidney Int,2000,57:1052-62.
  • 9蔡文莉,黄颂敏.C5b-9复合物与肾脏疾病研究进展[J].国外医学(泌尿系统分册),2003,23(5):568-571. 被引量:4
  • 10陈圳炜,唐德燊,刘华锋.Heymann肾炎发病机制的研究现状[J].广东医学院学报,2008,26(2):205-208. 被引量:5

二级参考文献98

  • 1[1]MORGAN BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects[J]. J Biochem, 1989,264(1) :1-4.
  • 2[2]KILGORE KS, SCHMID E , SHANLEY TP , et al.Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8and monocyte chemoattractant protein 1 through nuclear factor-kappa B activation[J]. Am J Pathol, 1997,150(6):2 019-2 031.
  • 3[3]KILGORE KS . SHEN JP , MILLER BF . et al . Enhancement by the complement membrane attack complex of tumor necrosis factor-a-induced endothelial cell expression of E-selection and ICAM-1 [J]. J Immunol.1995,155(3):1 434-1 441.
  • 4[4]KILGORE KS,FLORY CM.MILLER BF.et al. The membrane attack complex of complement induce interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells[J]. Am J Pathol.1996,149(3):953-961.
  • 5[5]SELVAN RS , KAPADIA HB, PLATT JL. Complement-induced expression of chemokine genes in endothelium:regulation by IL-1-dependent and IL-1-independent mechanisms[J]. J Immunol, 1998,161 (8): 4388-4 395.
  • 6[6]SUTTORP N,SEEGER W,ZINSKY S,et al. Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells [J]. Am J Physiol, 1987, 250(253) :C13-C21.
  • 7[7]HATTORI R,HAMILTON KK,MCEVER RP,et al.Complement proteins C5b-9 induce secretion of high moleular weight multimers of endothelial yon wille-brand factor and translocation of granule membrane protein GMP-140 to the cell surface[J]. J Biol Chem,[1989],264(15):9 053-9 060.
  • 8[8]BENZAQUEN LR , NICHOLSON WELLER A ,HALPERIN J. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-de-rived growth factor from endothelial cells [J]. J Exp Med,1994,179(3):985-992.
  • 9[9]SEEGER W , SUTTORP N , HELLCOIG A , et al.Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes[J]. J Immunol,1986,137(4):1 286-1 293.
  • 10[10]HANSCH GM, SEITZ M, MARTINOTTI G, et al.Macrophages release arachidonic acid, prostaglandin E2,and thromboxane in response to late complement components [J]. J Immunol, 1984, 133 (4): 2 145 -2 150.

共引文献7

同被引文献48

  • 1刘芳,蒲传强.多发性肌炎合并间质性肺病17例分析[J].脑与神经疾病杂志,2005,13(2):111-113. 被引量:5
  • 2刘芳,蒲传强,罗平,毛燕玲.坏死性肌病9例临床与病理分析[J].卒中与神经疾病,2005,12(3):149-151. 被引量:4
  • 3蒲传强.炎性肌病的诊断与鉴别诊断[J].中国现代神经疾病杂志,2007,7(2):107-111. 被引量:5
  • 4Ellis E, Ann Tan J, Lester S, et al. Necrotizing myopathy :clinicoserologic associations. Muscle Nerve, 2012, 45 (2) : 189-194.
  • 5Arlet JB, Dimitri D, Pagnoux C, et al. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) . Neuromuscul Disord, 2006 , 16 (5) : 334-336.
  • 6Dimitri D, Andre C, Roucoules J, et al. Myopathy associat- ed with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereo-typed histopathology. Mus- cle Nerve, 2007, 35(3) : 389-395.
  • 7Suzuki S, Satoh T, Sato S, et al. Clinical utility of anti- signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology ( Oxford ) , 2008 , 47 ( 10 ) : 1539-1542.
  • 8Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflam- matory myopathies, with the exception of inclusion body myo- sitis, 10-12 October 2003, Naarden, The Neth-erlands. Neuromuscul Disord, 2004, 14(5) : 337-345.
  • 9Chinoy H, Salway F, Fertig N, et al. In aduh onset myosi- tis, the presence of interstitial lung disease and myositis spe- cific/associated antibodies are governed by HLA class II hap- lotype, rather than by myositis subtype. Arthritis Res Ther, 2006, 8(1): RI3.
  • 10Miller T, A1- Lozi MT, Lopate G, et al. Myopathy with anti- bodies to the signal recognition particle : clinical and patholog- ic features. J Neurol Neurosurg Psychiatry, 2002, 73 : 420-428.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部